Amoxicillin Production Cost Analysis 2020

Amoxicillin is an antibiotic that is often used to treat several bacterial infections. These can be like the ones with a middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections, among others. It is taken orally or less commonly by injection. Moreover, its use during pregnancy and breastfeeding does not appear to be harmful.

Amoxicillin was discovered in the year 1958, and it came into medical use in 1972. It is a part of the beta-lactam family of antibiotics. It is on the WHO's List of Essential Medicines, the safest and most effective medicines needed in a health system. It is one of the most widely used antibiotics among children. Amoxicillin is available as a generic medication. In the year 2016, it was the 28th most prescribed medication in the United States, with more than 28 million prescriptions.

Procurement Resource provides an in-depth cost analysis of Amoxicillin production. The report incorporates the manufacturing process with detailed process and material flow, capital investment, operating costs along with financial expenses and depreciation charges. The study is based on the latest prices and other economic data available. We also offer additional analysis of the report with detailed breakdown of all cost components (Capital Investment Details, Production Cost Details, Economics for another Plant Location, Dynamic Cost Model).